+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Investigational New Drug CDMO Market - Global Forecast 2025-2030- Product Image
Investigational New Drug CDMO Market - Global Forecast 2025-2030- Product Image
Sale

Investigational New Drug CDMO Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130570
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The investigational drug contract manufacturing market is rapidly transforming as pharmaceutical and biotechnology companies intensify their demands for speed, compliance, and operational efficiency. Senior decision-makers require precise, actionable insights to align with this dynamic sector. This report delivers in-depth coverage of evolving technologies, changing regulatory landscapes, and shifting global strategies essential for selecting the right CDMO partners and optimizing investigational drug development pipelines.

Market Snapshot: Investigational Drug Contract Manufacturing

The global market for investigational drug contract manufacturing organizations (CDMOs) is experiencing strong growth, driven by innovation in therapeutic modalities, regulatory updates, and shifting sponsor requirements. The increasing adoption of digital analytics, continuous manufacturing, and agile supply chains is fueling new opportunities, while the move toward personalized medicine is influencing service models and facility design. CDMOs are also expanding their technical scope to better support complex biotech and pharmaceutical projects.

Scope & Segmentation of Investigational Drug CDMOs

This comprehensive report analyzes the market through a multi-dimensional lens, detailing services, molecule types, therapeutic focuses, scales of operation, key customer segments, manufacturing approaches, licensing models, regions, and leading company profiles. The research dissects the industry as follows:

  • Service Type: Analytical testing, clinical trial material manufacturing, commercial manufacturing, formulation development, packaging and labeling, regulatory support.
  • Molecule Type: Biologics (including cell therapy, monoclonal antibodies, recombinant proteins, vaccines), gene therapy, peptides, small molecules.
  • Therapeutic Area: Cardiovascular, central nervous system, immunology, infectious diseases, oncology (hematological malignancies and solid tumors).
  • Scale: Commercial, Phase I/II, Phase III, preclinical.
  • Customer Type: Academic institutions, biotech companies, pharmaceutical firms, virtual pharma entities.
  • Manufacturing Type: Batch and continuous processes.
  • Licensing Model: Collaborative research, fee-for-service, technology transfer.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, UAE, South Africa), Asia-Pacific (notably China, India, Japan, Australia, Southeast Asia).
  • Key Companies Profiled: Catalent Pharma Solutions, Lonza Group AG, Thermo Fisher Scientific, Samsung Biologics, WuXi AppTec, Boehringer Ingelheim BioXcellence, Fujifilm Diosynth, AGC Biologics, Recipharm AB, Ajinomoto Bio-Pharma Services.

Key Takeaways for Decision-Makers

  • The shift toward real-time digital analytics and predictive controls is improving batch consistency and accelerating validation across early and late-stage drug development.
  • Continuous manufacturing and modular, single-use facilities enhance flexibility, supporting rapid scale-up and adaptation to new therapeutic modalities such as gene and cell therapies.
  • Regulatory agencies are facilitating faster clinical progress with harmonized guidelines and collaboration incentives, but sponsors rely on CDMOs to interpret and act on complex and divergent regulatory requirements globally.
  • Strategically, CDMOs are investing in expanded regional footprints and digital supply chain platforms to manage increasing tariff complexities and geopolitical risk.
  • Collaboration between sponsors and CDMOs increasingly emphasizes risk sharing, robust contract structures, and transparent cost modeling to protect margins and ensure supply continuity.
  • Regional differences in infrastructure and regulatory maturity shape facility deployment, investment strategies, and access to emerging patient populations.

Tariff Impact on the CDMO Ecosystem

Forthcoming United States tariff policy adjustments in 2025 are generating significant concern for investigational drug CDMOs. Potential increases in the cost of raw materials push organizations to evaluate alternative sourcing and nearshore manufacturing options. This environment requires robust partnership agreements that address cost fluctuation risk, promote resilience through diversified supply networks, and preserve competitive positioning amidst operational expenditure uncertainty.

Methodology & Data Sources

This report applies a mixed-methodology framework, blending comprehensive secondary research—including regulatory documents, industry publications, and patent reviews—with direct primary interviews conducted across CDMOs, sponsors, and experts. Findings are reinforced by data triangulation and peer review, supporting the accuracy and relevance of all insights.

Why This Report Matters

  • Enables technology and operations leaders to identify best practices for agile, compliant, and scalable investigational drug manufacturing.
  • Provides clear guidance for structuring successful CDMO partnerships and mitigating risks from market, regulatory, or tariff disruptions.
  • Equips decision-makers with comprehensive intelligence to prioritize investments and regional strategies in a rapidly evolving landscape.

Conclusion

As investigational drug development becomes more complex, the CDMO sector’s ability to deliver integrated and compliant solutions remains a key strategic advantage. Leaders equipped with robust intelligence will be best-positioned to ensure timely, high-quality outcomes in a dynamic global market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for modular single-use bioreactor platforms to accelerate biologics scale-up and reduce cross-contamination risk
5.2. Increasing integration of continuous manufacturing processes to enhance efficiency and consistency in small molecule API production
5.3. Expansion of cell and gene therapy contract development capacity driven by rise in personalized and autologous therapies
5.4. Implementation of digital twin modeling and real-time PAT analytics for proactive quality control in biologics production
5.5. Strategic partnerships for mRNA and lipid nanoparticle formulation to support rapid vaccine development and global distribution
5.6. Adoption of green chemistry and sustainability initiatives to minimize environmental impact in pharmaceutical manufacturing
5.7. Shift toward near-shoring CDMO operations to mitigate supply chain disruptions and comply with regional regulatory requirements
5.8. Prioritization of quality by design frameworks and regulatory harmonization to expedite IND submissions and reduce review cycles
5.9. Increasing use of AI and machine learning in process optimization and predictive maintenance across CDMO manufacturing lines
5.10. Investment in cryogenic storage and cold chain capabilities to support advanced biologics and cell therapy commercial readiness
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Investigational New Drug CDMO Market, by Service Type
8.1. Introduction
8.2. Analytical Testing
8.2.1. Method Development And Validation
8.2.2. Release Testing
8.2.3. Stability Studies
8.3. Clinical Trial Material Manufacturing
8.3.1. Phase I/II Material
8.3.2. Phase III Material
8.4. Commercial Manufacturing
8.4.1. Batch Manufacturing
8.4.2. Continuous Manufacturing
8.5. Formulation Development
8.5.1. Lyophilized Formulation
8.5.2. Parenteral Formulation
8.5.3. Solid Dosage Form
8.6. Packaging And Labeling
8.7. Regulatory Support
8.7.1. CMC Documentation
8.7.2. IND Filing Support
9. Investigational New Drug CDMO Market, by Molecule Type
9.1. Introduction
9.2. Biologics
9.2.1. Cell Therapy
9.2.2. Monoclonal Antibodies
9.2.2.1. Antibody Drug Conjugates
9.2.2.2. Biosimilars
9.2.3. Recombinant Proteins
9.2.4. Vaccines
9.3. Gene Therapy
9.4. Peptides
9.5. Small Molecules
10. Investigational New Drug CDMO Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular
10.3. Central Nervous System
10.4. Immunology
10.5. Infectious Diseases
10.6. Oncology
10.6.1. Hematological Malignancies
10.6.2. Solid Tumors
11. Investigational New Drug CDMO Market, by Scale
11.1. Introduction
11.2. Commercial
11.3. Phase I/II
11.4. Phase III
11.5. Preclinical
12. Investigational New Drug CDMO Market, by Customer Type
12.1. Introduction
12.2. Academic Institutions
12.3. Biotech Companies
12.4. Pharmaceutical Companies
12.5. Virtual Pharma
13. Investigational New Drug CDMO Market, by Manufacturing Type
13.1. Introduction
13.2. Batch
13.3. Continuous
14. Investigational New Drug CDMO Market, by Licensing Model
14.1. Introduction
14.2. Collaborative Research
14.3. Fee-for-Service
14.4. Technology Transfer
15. Americas Investigational New Drug CDMO Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Investigational New Drug CDMO Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Investigational New Drug CDMO Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Catalent Pharma Solutions, Inc.
18.3.2. Lonza Group AG
18.3.3. Thermo Fisher Scientific Inc.
18.3.4. Samsung Biologics Co., Ltd.
18.3.5. WuXi AppTec Co., Ltd.
18.3.6. Boehringer Ingelheim BioXcellence GmbH
18.3.7. Fujifilm Diosynth Biotechnologies US, LLC
18.3.8. AGC Biologics, Inc.
18.3.9. Recipharm AB
18.3.10. Ajinomoto Bio-Pharma Services, LLC
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. INVESTIGATIONAL NEW DRUG CDMO MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. INVESTIGATIONAL NEW DRUG CDMO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. INVESTIGATIONAL NEW DRUG CDMO MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. INVESTIGATIONAL NEW DRUG CDMO MARKET: RESEARCHAI
FIGURE 30. INVESTIGATIONAL NEW DRUG CDMO MARKET: RESEARCHSTATISTICS
FIGURE 31. INVESTIGATIONAL NEW DRUG CDMO MARKET: RESEARCHCONTACTS
FIGURE 32. INVESTIGATIONAL NEW DRUG CDMO MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INVESTIGATIONAL NEW DRUG CDMO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY METHOD DEVELOPMENT AND VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY METHOD DEVELOPMENT AND VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY RELEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY RELEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE I/II MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE I/II MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE III MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE III MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LYOPHILIZED FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PARENTERAL FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PARENTERAL FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SOLID DOSAGE FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SOLID DOSAGE FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PACKAGING AND LABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PACKAGING AND LABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CMC DOCUMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CMC DOCUMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY IND FILING SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY IND FILING SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE I/II, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE I/II, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY VIRTUAL PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY VIRTUAL PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COLLABORATIVE RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COLLABORATIVE RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FEE-FOR-SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FEE-FOR-SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY TECHNOLOGY TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY TECHNOLOGY TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 202. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 203. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 204. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 205. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 206. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 207. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 208. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 209. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 210. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 211. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 214. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 215. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 216. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 217. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 218. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 219. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 222. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 223. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 224. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 225. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 226. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 227. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 228. CANADA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 229. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 232. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 233. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 234. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 235. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 236. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 237. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 238. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 239. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 240. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 241. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 248. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 249. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 258. MEXICO INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY REGULATORY SUPPORT, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY MANUFACTURING TYPE, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY LICENSING MODEL, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO MARKET SIZE, BY COMMERCIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA INVESTIGATIONAL NEW DRUG CDMO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Investigational New Drug CDMO market report include:
  • Catalent Pharma Solutions, Inc.
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Samsung Biologics Co., Ltd.
  • WuXi AppTec Co., Ltd.
  • Boehringer Ingelheim BioXcellence GmbH
  • Fujifilm Diosynth Biotechnologies US, LLC
  • AGC Biologics, Inc.
  • Recipharm AB
  • Ajinomoto Bio-Pharma Services, LLC

Related Topics

Related Reports

Investigational New Drug CDMO - Global Strategic Business Report - Product Image

Investigational New Drug CDMO - Global Strategic Business Report

  • Report
  • 162 Pages
  • Global
From
Live Biotherapeutic Products & Microbiome CDMO Service Market - Global Forecast 2025-2030 - Product Image

Live Biotherapeutic Products & Microbiome CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Large Molecule Drug Substance CDMO Market - Global Forecast 2025-2030 - Product Image

Large Molecule Drug Substance CDMO Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.